Studies of mechanisms of antibody formation. III. Effects of 5-bromodeoxyuridine upon normal and neoplastic B-lymphocyte function.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000921:Antibody-Producing Cells / Q000276:immunology; D000941:Antigens; D001402:B-Lymphocytes / Q000276:immunology*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis; D007070:Immunoglobulin A / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis; D007147:Immunoglobulin Light Chains / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007148:Immunoglobulin mu-Chains / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D010954:Plasmacytoma / Q000276:immunology*; D012313:RNA / Q000096:biosynthesis; D011947:Receptors, Antigen, B-Cell / Q000096:biosynthesis
D000941:Antigens; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007147:Immunoglobulin Light Chains; D007075:Immunoglobulin M; D007148:Immunoglobulin mu-Chains; D008070:Lipopolysaccharides; D011947:Receptors, Antigen, B-Cell; D012313:RNA; D004247:DNA; D001973:Bromodeoxyuridine